Search

Exposure to adversity and life stress can be extremely detrimental to neurobiological processes and associated with numerous maladaptive physiological and cognitive outcomes. Individuals who report encountering chronic or severe stress report decreased emotion regulation skills, as well as decrements in the ability to perceive and understand their own, as well as others’ emotions (Chrousos, 2000). Furthermore, exposure to stress and adversity often results in blunted autonomic reactivity, especially when encountered during earlier periods of biological development, often manifesting in internalizing and externalizing psychopathologies (Porges, 2007). However, there is a high level of interindividual variability regarding resilience and the capacity to regulate emotions when individuals encounter adverse events.The extent to which emotion and cognition contribute to positive behavioral outcomes is thought to be a unique set of abilities, separate from general intelligence (IQ). Debates regarding the various facets of these unique capabilities have propelled the field to develop a unified construct describing specific abilities, known as Emotional Intelligence (EI) (Salovey and Mayer, 1990). The theoretical underpinnings of EI remain an active topic of debate, yet a consistent theme in the various conceptualizations is that EI should contribute to mitigating and managing the different life stressors an individual could encounter over the lifespan. When individuals are unable to manage or recover from stressful or traumatic experiences the persistent maladaptive symptoms experienced become conceptualized as Post Traumatic Stress Disorder (PTSD). A hallmark symptom associated with PTSD is sleep disruption and/or nightmares (Germain, 2013). Numerous pharmacologic and non-invasive modalities have been utilized to decrease the suffering associated with PTSD, and interventions targeting sleep have been suggested as a means of facilitating decreases in symptom presentations